Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

被引:19
作者
McNaughton-Collins, M [1 ]
Barry, MJ [1 ]
机构
[1] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA
关键词
benign prostatic hyperplasia; diagnosis; treatment;
D O I
10.1016/j.amjmed.2004.12.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia can be managed safely and effectively by primary care providers. After a basic evaluation to exclude other diseases that may cause lower urinary tract symptoms, quantifying the degree of symptoms and bother,and perhaps making an assessment of prostate size, the primary care provider can determine which men require immediate evaluation by a urologist and which men may choose among various treatment options, including watchful waiting and various single agent or combination medication strategies. Recent information about risk factors for disease progression has also helped to inform patient decisions on which treatment option is best for the individual patient. The purpose of this review is to provide primary care providers with an approach to the management of men with lower Urinary tract symptoms suggestive of benign prostatic hyperplasia. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1331 / 1339
页数:9
相关论文
共 59 条
[41]   Low AUA symptom score independently predicts positive prostate needle biopsy: Results from a racially diverse series of 411 patients [J].
Porter, CR ;
Kim, J .
UROLOGY, 2004, 63 (01) :90-94
[42]   Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia [J].
Roehrborn, CG ;
Bruskewitz, R ;
Nickel, JC ;
McConnell, JD ;
Saltzman, B ;
Gittelman, MC ;
Malek, GH ;
Gottesman, JE ;
Suryawanshi, S ;
Drisko, J ;
Meehan, A ;
Waldstreicher, J .
JOURNAL OF UROLOGY, 2004, 171 (03) :1194-1198
[43]   Urinary retention in patients with BPH treated with finasteride or placebo over 4 years - Characterization of patients and ultimate outcomes [J].
Roehrborn, CG ;
Bruskewitz, R ;
Nickel, GC ;
Glickman, S ;
Cox, C ;
Anderson, R ;
Kandzari, S ;
Herlihy, R ;
Kornitzer, G ;
Brown, BT ;
Holtgrewe, HL ;
Taylor, A ;
Wang, D ;
Waldstreicher, J .
EUROPEAN UROLOGY, 2000, 37 (05) :528-536
[44]  
Roehrborn CG, 2003, NEW ENGL J MED, V349, P1569
[45]   Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia [J].
Roehrborn, CG ;
McConnell, J ;
Bonilla, J ;
Rosenblatt, S ;
Hudson, PB ;
Malek, GH ;
Schellhammer, PF ;
Bruskewitz, R ;
Matsumoto, AM ;
Harrison, LH ;
Fuselier, HA ;
Walsh, P ;
Roy, J ;
Andriole, G ;
Resnick, M ;
Waldstreicher, J .
JOURNAL OF UROLOGY, 2000, 163 (01) :13-20
[46]   Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound [J].
Roehrborn, CG ;
Girman, CJ ;
Rhodes, T ;
Hanson, KA ;
Collins, GN ;
Sech, SM ;
Jacobsen, SJ ;
Garraway, WM ;
Lieber, MM .
UROLOGY, 1997, 49 (04) :548-557
[47]   Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia [J].
Roehrborn, CG ;
McConnell, JD ;
Lieber, M ;
Kaplan, S ;
Geller, J ;
Malek, GH ;
Castellanos, R ;
Coffield, S ;
Saltzman, B ;
Resnick, M ;
Cook, TJ ;
Waldstreicher, J .
UROLOGY, 1999, 53 (03) :473-480
[48]   Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia [J].
Roehrborn, CG ;
Boyle, P ;
Nickel, JC ;
Hoefner, K ;
Andriole, G .
UROLOGY, 2002, 60 (03) :434-441
[49]   Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia [J].
Roehrborn, CG ;
Boyle, P ;
Gould, AL ;
Waldstreicher, J .
UROLOGY, 1999, 53 (03) :581-589
[50]   Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: A comprehensive analysis of the pooled placebo groups of several large clinical trials [J].
Roehrborn, CG ;
Malice, MP ;
Cook, TJ ;
Girman, CJ .
UROLOGY, 2001, 58 (02) :210-216